Insider Trading activities of Genomic Health Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005. The reporting company's ticker symbol is GHDX. The reporting company's CIK number is 1131324.
The total value of stock buying since 2005 is $429,915,827.
The total value of stock sales since 2005 is $56,864,673.
The total value of stock option exercises since 2005 is $5,053,425.


Go to page:  1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Genomic Health Inc (GHDX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2014-12 0 $0 7,336 $240,233 7,336 $97,385
2014-11 0 $0 11,300 $399,872 11,300 $150,977
2014-10 0 $0 7,000 $207,421 7,000 $94,230
2014-09 0 $0 7,700 $230,872 7,700 $71,254
2014-08 0 $0 16,348 $443,430 16,348 $66,612
2014-07 0 $0 12,300 $330,956 12,300 $54,954
2014-06 0 $0 16,337 $439,288 16,337 $127,200
2014-05 0 $0 7,000 $180,691 7,000 $100,310
2014-04 0 $0 10,000 $266,654 10,000 $28,800
2014-03 0 $0 10,000 $281,781 10,000 $28,800
2014-02 0 $0 11,312 $309,215 10,000 $28,800
2014-01 0 $0 12,500 $380,099 12,500 $52,275
2013-12 0 $0 20,500 $625,409 20,500 $126,290
2013-11 0 $0 10,868 $362,423 10,868 $102,753
2013-10 0 $0 10,000 $298,225 5,000 $18,662
2013-09 0 $0 15,000 $498,838 10,000 $90,275
2013-08 0 $0 14,000 $464,197 9,000 $79,245
2013-07 0 $0 16,500 $568,261 11,500 $87,045
2013-06 509,773 $18,501,177 12,500 $438,906 7,500 $83,375
2013-05 563,790 $20,185,361 20,087 $721,927 15,087 $135,626
2013-04 0 $0 5,000 $144,482 5,000 $10,525
2013-03 0 $0 2,500 $71,435 2,500 $3,325
2013-02 217,445 $6,119,759 46,466 $1,318,016 43,750 $781,960
2013-01 0 $0 7,125 $200,739 7,125 $30,627
2012-12 0 $0 15,500 $431,107 5,500 $31,495
2012-11 1,156,239 $31,525,505 48,116 $1,306,607 7,500 $34,149
2012-10 0 $0 21,750 $736,466 11,750 $174,382
2012-09 0 $0 12,500 $414,765 2,500 $3,325
2012-08 0 $0 34,000 $1,180,157 32,250 $372,570
2012-07 0 $0 46,600 $1,652,117 6,600 $54,930
2012-06 0 $0 42,500 $1,429,860 2,500 $3,325
2012-05 854,973 $26,965,075 74,794 $2,398,312 7,500 $119,875
2012-04 0 $0 35,500 $1,013,613 4,500 $5,979
2012-03 428,145 $12,789,188 63,500 $1,939,635 2,500 $3,325
2012-02 1,846,592 $52,044,225 38,255 $1,037,135 2,500 $3,325
2012-01 0 $0 40,500 $1,103,159 4,500 $5,979
2011-12 304,071 $8,528,204 27,500 $753,560 2,500 $3,325
2011-11 1,415,609 $37,478,369 27,500 $741,665 7,500 $50,275
2011-10 0 $0 32,000 $721,125 12,000 $56,254
2011-09 0 $0 27,500 $569,710 7,500 $50,275
2011-08 0 $0 27,500 $666,981 7,500 $50,275
2011-07 0 $0 32,000 $876,856 12,000 $56,254
2011-06 491,170 $12,969,827 28,500 $740,781 7,500 $50,275
2011-05 116,208 $3,167,096 28,500 $752,196 7,500 $50,275
2011-04 0 $0 41,000 $1,061,996 15,000 $124,724
2011-03 1,019,260 $25,953,993 70,820 $1,789,399 13,000 $122,070
2011-02 85,476 $2,144,763 34,000 $762,991 18,000 $183,495
2011-01 0 $0 34,276 $741,307 14,276 $33,364
2010-12 0 $0 30,500 $687,520 10,500 $26,365
2010-11 0 $0 30,500 $550,440 60,500 $542,865
2010-10 0 $0 20,000 $279,000 0 $0
2010-09 51,342 $745,705 30,234 $451,764 10,234 $25,598
2010-08 864,973 $12,611,379 35,129 $520,597 10,500 $26,365
2010-07 0 $0 24,629 $316,583 0 $0
2010-06 0 $0 24,629 $347,952 0 $0
2010-05 0 $0 35,129 $550,000 10,500 $26,365
2010-04 0 $0 29,629 $500,051 5,000 $6,650
2010-03 0 $0 153,829 $2,990,247 2,500 $3,325
2010-02 500,088 $8,496,802 27,129 $467,639 2,500 $3,325
2010-01 0 $0 9,629 $167,114 5,000 $6,650
2009-12 0 $0 28,629 $580,159 0 $0
2009-11 0 $0 37,294 $730,015 665 $884
2009-10 0 $0 26,629 $551,250 0 $0
2009-09 0 $0 26,629 $550,538 0 $0
2009-08 360,972 $7,116,249 31,629 $624,684 5,000 $6,650
2009-07 0 $0 4,629 $74,114 0 $0
2009-06 0 $0 10,629 $191,497 0 $0
2009-05 321,783 $6,216,101 26,629 $520,450 0 $0
2009-04 0 $0 16,629 $425,350 0 $0
2009-03 0 $0 16,629 $321,343 0 $0
2009-02 0 $0 21,629 $455,022 5,000 $6,650
2009-01 0 $0 4,629 $89,858 0 $0
2008-12 0 $0 16,729 $311,955 69,348 $219,833
2008-11 0 $0 26,629 $535,565 10,000 $13,300
2008-10 0 $0 25,887 $553,977 0 $0
2008-09 0 $0 30,887 $691,589 0 $0
2008-08 0 $0 55,927 $1,330,867 5,000 $6,650
2008-07 0 $0 16,629 $341,136 0 $0
2008-06 493,611 $9,796,688 16,729 $324,292 0 $0
2008-05 0 $0 16,629 $314,159 0 $0
2008-04 0 $0 12,000 $206,658 0 $0
2008-03 0 $0 16,629 $320,821 0 $0
2008-02 0 $0 30,629 $686,732 10,201 $9,645
2008-01 0 $0 16,629 $411,393 0 $0
2007-12 0 $0 4,629 $106,906 0 $0
2007-11 0 $0 11,284 $253,849 0 $0
2007-10 0 $0 16,629 $333,777 0 $0
2007-09 0 $0 40,629 $799,617 0 $0
2007-08 5,350 $100,387 16,629 $328,861 0 $0
2007-07 0 $0 16,629 $342,235 0 $0
2007-06 0 $0 16,629 $311,131 0 $0
2007-05 4,000,143 $64,065,260 16,629 $274,912 0 $0
2007-04 0 $0 16,629 $286,649 43,345 $27,480
2007-03 628,786 $11,484,376 16,629 $304,353 0 $0
2007-02 811,781 $14,845,020 16,629 $305,182 0 $0
2006-12 953,338 $19,285,985 0 $0 0 $0
2006-09 1,195,954 $16,779,333 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Genomic Health Inc insiders (GHDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-12-11 Popovits Kimberly J (President and CEO) Sale 3,000 33.08 99,231
2014-12-11 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2014-12-08 Cole G Bradley (COO) Sale 4,336 32.52 141,002
2014-12-08 Cole G Bradley (COO) Option Ex 4,336 9.39 40,715
2014-11-12 Popovits Kimberly J (President and CEO) Sale 4,300 34.83 149,764
2014-11-12 Popovits Kimberly J (President and CEO) Option Ex 4,300 18.89 81,227
2014-11-10 Cole G Bradley (COO) Sale 4,000 35.35 141,388
2014-11-10 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2014-11-03 Livingston Randall S (Director) Sale 3,000 36.24 108,720
2014-11-03 Livingston Randall S (Director) Option Ex 3,000 10.73 32,190
2014-10-13 Popovits Kimberly J (President and CEO) Sale 3,000 30.78 92,325
2014-10-13 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2014-10-08 Cole G Bradley (COO) Sale 4,000 28.77 115,096
2014-10-08 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2014-09-11 Popovits Kimberly J (President and CEO) Sale 3,000 29.82 89,445
2014-09-11 Popovits Kimberly J (President and CEO) Option Ex 3,000 14.14 42,420
2014-09-08 Cole G Bradley (COO) Sale 4,700 30.09 141,427
2014-09-08 Cole G Bradley (COO) Option Ex 4,700 6.14 28,834
2014-08-14 Shak Steven (EVP of R&D) Sale 6,348 27.49 174,500
2014-08-14 Shak Steven (EVP of R&D) Option Ex 6,348 2.88 18,282
2014-08-13 Shak Steven (EVP of R&D) Sale 7,000 27.25 190,729
2014-08-13 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-08-12 Popovits Kimberly J (President and CEO) Sale 3,000 26.07 78,201
2014-08-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-07-14 Popovits Kimberly J (President and CEO) Sale 3,000 26.59 79,776
2014-07-14 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-07-08 Cole G Bradley (COO) Sale 2,300 27.05 62,208
2014-07-08 Cole G Bradley (COO) Option Ex 2,300 2.88 6,624
2014-07-01 Shak Steven (EVP of R&D) Sale 7,000 27.00 188,972
2014-07-01 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-06-12 Shak Steven (EVP of R&D) Sale 7,000 26.68 186,739
2014-06-12 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-06-12 Popovits Kimberly J (President and CEO) Sale 3,000 26.10 78,294
2014-06-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-06-10 Schorno Dean L (CFO) Sale 4,000 27.62 110,488
2014-06-10 Schorno Dean L (CFO) Option Ex 4,000 18.04 72,140
2014-06-09 Cole G Bradley (COO) Sale 2,337 27.29 63,767
2014-06-09 Cole G Bradley (COO) Option Ex 2,337 2.88 6,730
2014-05-12 Popovits Kimberly J (President and CEO) Sale 3,000 26.78 80,331
2014-05-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-05-09 Schorno Dean L (CFO) Sale 4,000 25.09 100,360
2014-05-09 Schorno Dean L (CFO) Option Ex 4,000 18.04 72,140
2014-04-14 Shak Steven (EVP of R&D) Sale 7,000 26.52 185,654
2014-04-14 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-04-08 Cole G Bradley (COO) Sale 3,000 27.00 81,000
2014-04-08 Cole G Bradley (COO) Option Ex 3,000 2.88 8,640
2014-03-14 Shak Steven (EVP of R&D) Sale 7,000 28.36 198,492
2014-03-14 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-03-10 Cole G Bradley (COO) Sale 3,000 27.76 83,289
2014-03-10 Cole G Bradley (COO) Option Ex 3,000 2.88 8,640
2014-02-18 Hibbs Kathy L (SVP & General Counsel) Sale 1,312 27.88 36,583
2014-02-14 Shak Steven (EVP of R&D) Sale 7,000 27.38 191,632
2014-02-14 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-02-10 Cole G Bradley (COO) Sale 3,000 27.00 81,000
2014-02-10 Cole G Bradley (COO) Option Ex 3,000 2.88 8,640
2014-01-15 Shak Steven (EVP of R&D) Sale 7,000 31.51 220,598
2014-01-15 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-01-13 Popovits Kimberly J (President and CEO) Sale 2,500 30.00 75,000
2014-01-13 Popovits Kimberly J (President and CEO) Option Ex 2,500 9.39 23,475
2014-01-08 Cole G Bradley (COO) Sale 3,000 28.17 84,501
2014-01-08 Cole G Bradley (COO) Option Ex 3,000 2.88 8,640
2013-12-17 Shak Steven (EVP of R&D & CMO) Sale 7,000 29.24 204,673
2013-12-17 Shak Steven (EVP of R&D & CMO) Option Ex 7,000 2.88 20,160
2013-12-16 Shak Steven (EVP of R&D & CMO) Sale 7,000 29.91 209,349
2013-12-16 Shak Steven (EVP of R&D & CMO) Option Ex 7,000 2.88 20,160
2013-12-12 Popovits Kimberly J (President and CEO) Sale 2,500 30.68 76,705
2013-12-12 Popovits Kimberly J (President and CEO) Option Ex 2,500 9.39 23,475
2013-12-09 Schorno Dean L (CFO) Sale 3,000 33.25 99,762
2013-12-09 Schorno Dean L (CFO) Option Ex 3,000 17.26 51,765
2013-12-02 Livingston Randall S (Director) Sale 1,000 34.92 34,920
2013-12-02 Livingston Randall S (Director) Option Ex 1,000 10.73 10,730
2013-11-13 Popovits Kimberly J (President and CEO) Sale 2,500 35.00 87,500
2013-11-13 Popovits Kimberly J (President and CEO) Option Ex 2,500 9.39 23,475
2013-11-12 Popovits Kimberly J (President and CEO) Sale 2,500 34.17 85,422
2013-11-12 Popovits Kimberly J (President and CEO) Option Ex 2,500 9.39 23,475
2013-11-08 Schorno Dean L (CFO) Sale 3,000 33.36 100,089
2013-11-08 Schorno Dean L (CFO) Option Ex 3,000 17.33 51,989
2013-11-06 Cole G Bradley (COO) Sale 2,868 31.18 89,412
2013-11-06 Cole G Bradley (COO) Option Ex 2,868 1.33 3,814
2013-10-15 Shak Steven (EVP of R&D & CMO) Sale 5,000 29.67 148,340
2013-10-10 Popovits Kimberly J (President and CEO) Sale 2,500 30.00 75,000
2013-10-10 Popovits Kimberly J (President and CEO) Option Ex 2,500 6.14 15,337
2013-10-09 Cole G Bradley (COO) Sale 2,500 29.95 74,885
2013-10-09 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-09-18 Shak Steven (EVP of R&D & CMO) Sale 5,000 33.73 168,630
2013-09-12 Popovits Kimberly J (President and CEO) Sale 2,500 34.32 85,787
2013-09-12 Popovits Kimberly J (President and CEO) Option Ex 2,500 2.88 7,200
2013-09-09 Cole G Bradley (COO) Sale 2,500 32.53 81,329
2013-09-09 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-09-06 Schorno Dean L (CFO) Sale 4,000 32.90 131,600
2013-09-06 Schorno Dean L (CFO) Option Ex 4,000 17.26 69,020
2013-09-03 Livingston Randall S (Director) Sale 1,000 31.49 31,492
2013-09-03 Livingston Randall S (Director) Option Ex 1,000 10.73 10,730
2013-08-14 Shak Steven (EVP of R&D & CMO) Sale 5,000 32.98 164,905
2013-08-12 Popovits Kimberly J (President and CEO) Sale 2,500 33.03 82,572
2013-08-12 Popovits Kimberly J (President and CEO) Option Ex 2,500 2.88 7,200
2013-08-09 Schorno Dean L (CFO) Sale 4,000 33.14 132,580
2013-08-09 Schorno Dean L (CFO) Option Ex 4,000 17.18 68,720
2013-08-07 Cole G Bradley (COO) Sale 2,500 33.66 84,140
2013-08-07 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-07-23 Shak Steven (EVP of R&D & CMO) Sale 5,000 35.33 176,670
2013-07-12 Popovits Kimberly J (President and CEO) Sale 2,100 35.00 73,500
2013-07-12 Popovits Kimberly J (President and CEO) Option Ex 2,100 2.88 6,048
2013-07-11 Popovits Kimberly J (President and CEO) Sale 2,900 34.32 99,528
2013-07-11 Popovits Kimberly J (President and CEO) Option Ex 2,900 2.88 8,352
2013-07-09 Schorno Dean L (CFO) Sale 4,000 33.81 135,236
2013-07-09 Schorno Dean L (CFO) Option Ex 4,000 17.33 69,320
2013-07-08 Cole G Bradley (COO) Sale 2,500 33.33 83,327
2013-07-08 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-06-18 Shak Steven (EVP of R&D & CMO) Sale 5,000 33.56 167,810
2013-06-10 Schorno Dean L (CFO) Sale 4,000 35.88 143,524
2013-06-10 Schorno Dean L (CFO) Option Ex 4,000 17.33 69,320
2013-06-05 Cole G Bradley (COO) Sale 2,500 36.47 91,172
2013-06-05 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-06-05 Baker Bros Advisors Llc (Director) Buy 217,773 35.82 7,799,539
2013-06-04 Baker Bros Advisors Llc (Director) Buy 163,659 36.62 5,993,192
2013-06-03 Baker Bros Advisors Llc (Director) Buy 128,341 36.69 4,708,446
2013-06-03 Livingston Randall S (Director) Sale 1,000 36.40 36,400
2013-06-03 Livingston Randall S (Director) Option Ex 1,000 10.73 10,730
2013-05-31 Baker Bros Advisors Llc (Director) Buy 51,242 36.75 1,883,245
2013-05-29 Baker Bros Advisors Llc (Director) Buy 47,000 36.82 1,730,634
2013-05-28 Baker Bros Advisors Llc (Director) Buy 74,266 36.93 2,742,940
2013-05-24 Baker Bros Advisors Llc (Director) Buy 62,517 36.93 2,308,877
2013-05-23 Baker Bros Advisors Llc (Director) Buy 16,900 36.58 618,286
2013-05-22 Hibbs Kathy L (SVP & General Counsel) Sale 1,000 37.48 37,480
2013-05-22 Hibbs Kathy L (SVP & General Counsel) Option Ex 1,000 21.07 21,070
2013-05-21 Shak Steven (EVP of R&D & CMO) Sale 5,000 37.19 185,955
2013-05-16 Baker Bros Advisors Llc (Director) Buy 19,306 36.54 705,421
2013-05-15 Baker Bros Advisors Llc (Director) Buy 52,133 36.41 1,898,371
2013-05-15 Livingston Randall S (Director) Sale 1,337 35.83 47,903
2013-05-15 Livingston Randall S (Director) Option Ex 1,337 1.33 1,774
2013-05-14 Baker Bros Advisors Llc (Director) Buy 27,184 35.53 965,901
2013-05-13 Popovits Kimberly J (President and CEO) Sale 5,000 34.70 173,505
2013-05-13 Popovits Kimberly J (President and CEO) Option Ex 5,000 2.88 14,400
2013-05-13 Hibbs Kathy L (SVP & General Counsel) Sale 1,250 34.42 43,031
2013-05-13 Hibbs Kathy L (SVP & General Counsel) Option Ex 1,250 21.07 26,337
2013-05-13 Baker Bros Advisors Llc (Director) Buy 213,242 34.38 7,331,686
2013-05-09 Schorno Dean L (CFO) Sale 4,000 36.02 144,088
2013-05-09 Schorno Dean L (CFO) Option Ex 4,000 17.18 68,720
2013-05-08 Cole G Bradley (COO) Sale 2,500 35.99 89,965
2013-05-08 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-04-23 Popovits Kimberly J (President and CEO) Sale 2,500 30.00 75,000
2013-04-23 Popovits Kimberly J (President and CEO) Option Ex 2,500 2.88 7,200
2013-04-03 Cole G Bradley (COO) Sale 2,500 27.79 69,482
2013-04-03 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-03-06 Cole G Bradley (COO) Sale 2,500 28.57 71,435
2013-03-06 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-02-21 Baker Bros Advisors Llc (Director) Buy 28,200 27.64 779,335
2013-02-20 Hibbs Kathy L (SVP & General Counsel) Sale 2,716 28.13 76,398
2013-02-20 Baker Bros Advisors Llc (Director) Buy 20,885 27.97 584,216
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.